[[5-[[(3R)-oxolan-3-yl]amino]-2-(trifluoromethyl)-1,3-thiazol-4-yl]-[(E)-N'-[(3R)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamimidoyl]oxymethylidene]azanide

C25H21F3N7O3S- — CID 145236277

IUPAC[[5-[[(3R)-oxolan-3-yl]amino]-2-(trifluoromethyl)-1,3-thiazol-4-yl]-[(E)-N'-[(3R)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamimidoyl]oxymethylidene]azanide
SMILES[N-]=C(O/C(N)=N/[C@H]1N=C(c2ccccc2)c2ccccc2NC1=O)c1nc(C(F)(F)F)sc1N[C@@H]1CCOC1
InChIInChI=1S/C25H21F3N7O3S/c26-25(27,28)23-34-18(22(39-23)31-14-10-11-37-12-14)19(29)38-24(30)35-20-21(36)32-16-9-5-4-8-15(16)17(33-20)13-6-2-1-3-7-13/h1-9,14,20,31H,10-12H2,(H2,30,35)(H,32,36)/q-1/t14-,20-/m1/s1
InChIKeyJIFSXEAQBIXGCS-JLTOFOAXSA-N
MW556.55 g/mol
LogP3.83
Rot. Bonds5

About [[5-[[(3R)-oxolan-3-yl]amino]-2-(trifluoromethyl)-1,3-thiazol-4-yl]-[(E)-N'-[(3R)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamimidoyl]oxymethylidene]azanide

[[5-[[(3R)-oxolan-3-yl]amino]-2-(trifluoromethyl)-1,3-thiazol-4-yl]-[(E)-N'-[(3R)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamimidoyl]oxymethylidene]azanide (PubChem CID 145236277) has the molecular formula C25H21F3N7O3S- and a molecular weight of 556.55 g/mol. Its IUPAC name is [[5-[[(3R)-oxolan-3-yl]amino]-2-(trifluoromethyl)-1,3-thiazol-4-yl]-[(E)-N'-[(3R)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamimidoyl]oxymethylidene]azanide.

Molecular Properties

Compound Name[[5-[[(3R)-oxolan-3-yl]amino]-2-(trifluoromethyl)-1,3-thiazol-4-yl]-[(E)-N'-[(3R)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamimidoyl]oxymethylidene]azanide
PubChem CID145236277
Molecular FormulaC25H21F3N7O3S-
Molecular Weight556.55 g/mol
Exact Mass556.14
IUPAC Name[[5-[[(3R)-oxolan-3-yl]amino]-2-(trifluoromethyl)-1,3-thiazol-4-yl]-[(E)-N'-[(3R)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamimidoyl]oxymethylidene]azanide
SMILES[N-]=C(O/C(N)=N/[C@H]1N=C(c2ccccc2)c2ccccc2NC1=O)c1nc(C(F)(F)F)sc1N[C@@H]1CCOC1
InChIInChI=1S/C25H21F3N7O3S/c26-25(27,28)23-34-18(22(39-23)31-14-10-11-37-12-14)19(29)38-24(30)35-20-21(36)32-16-9-5-4-8-15(16)17(33-20)13-6-2-1-3-7-13/h1-9,14,20,31H,10-12H2,(H2,30,35)(H,32,36)/q-1/t14-,20-/m1/s1
InChIKeyJIFSXEAQBIXGCS-JLTOFOAXSA-N
XLogP3.83
TPSA145.52 Ų
H-Bond Donors3
H-Bond Acceptors8
Rotatable Bonds5
Heavy Atoms39
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500556.55
LogP ≤ 53.83
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze [[5-[[(3R)-oxolan-3-yl]amino]-2-(trifluoromethyl)-1,3-thiazol-4-yl]-[(E)-N'-[(3R)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamimidoyl]oxymethylidene]azanide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [[5-[[(3R)-oxolan-3-yl]amino]-2-(trifluoromethyl)-1,3-thiazol-4-yl]-[(E)-N'-[(3R)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamimidoyl]oxymethylidene]azanide?
The IUPAC name of [[5-[[(3R)-oxolan-3-yl]amino]-2-(trifluoromethyl)-1,3-thiazol-4-yl]-[(E)-N'-[(3R)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamimidoyl]oxymethylidene]azanide (CID 145236277) is [[5-[[(3R)-oxolan-3-yl]amino]-2-(trifluoromethyl)-1,3-thiazol-4-yl]-[(E)-N'-[(3R)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamimidoyl]oxymethylidene]azanide.
What is the SMILES notation for [[5-[[(3R)-oxolan-3-yl]amino]-2-(trifluoromethyl)-1,3-thiazol-4-yl]-[(E)-N'-[(3R)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamimidoyl]oxymethylidene]azanide?
The canonical SMILES for [[5-[[(3R)-oxolan-3-yl]amino]-2-(trifluoromethyl)-1,3-thiazol-4-yl]-[(E)-N'-[(3R)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamimidoyl]oxymethylidene]azanide is [N-]=C(O/C(N)=N/[C@H]1N=C(c2ccccc2)c2ccccc2NC1=O)c1nc(C(F)(F)F)sc1N[C@@H]1CCOC1.
What is the InChIKey of [[5-[[(3R)-oxolan-3-yl]amino]-2-(trifluoromethyl)-1,3-thiazol-4-yl]-[(E)-N'-[(3R)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamimidoyl]oxymethylidene]azanide?
The InChIKey is JIFSXEAQBIXGCS-JLTOFOAXSA-N. The full InChI is InChI=1S/C25H21F3N7O3S/c26-25(27,28)23-34-18(22(39-23)31-14-10-11-37-12-14)19(29)38-24(30)35-20-21(36)32-16-9-5-4-8-15(16)17(33-20)13-6-2-1-3-7-13/h1-9,14,20,31H,10-12H2,(H2,30,35)(H,32,36)/q-1/t14-,20-/m1/s1.
What are the key properties of [[5-[[(3R)-oxolan-3-yl]amino]-2-(trifluoromethyl)-1,3-thiazol-4-yl]-[(E)-N'-[(3R)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamimidoyl]oxymethylidene]azanide?
[[5-[[(3R)-oxolan-3-yl]amino]-2-(trifluoromethyl)-1,3-thiazol-4-yl]-[(E)-N'-[(3R)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamimidoyl]oxymethylidene]azanide has a molecular weight of 556.55 g/mol, XLogP of 3.83, 5 rotatable bonds, 3 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for [[5-[[(3R)-oxolan-3-yl]amino]-2-(trifluoromethyl)-1,3-thiazol-4-yl]-[(E)-N'-[(3R)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamimidoyl]oxymethylidene]azanide is sourced from PubChem (CID 145236277), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).